Varicose Vein Treatment Market Share, Size, Trends, Industry Analysis Report, By Treatment Mode (Endovenous Ablation, Injection Sclerotherapy, Surgical Ligation/Stripping); By Products; By End User; By Region; Segment Forecast, 2023 - 2032

Varicose Vein Treatment Market Share, Size, Trends, Industry Analysis Report, By Treatment Mode (Endovenous Ablation, Injection Sclerotherapy, Surgical Ligation/Stripping); By Products; By End User; By Region; Segment Forecast, 2023 - 2032

The global varicose vein treatment market size is expected to reach USD 2,052.48 million by 2032, according to a new study by Polaris Market Research. The report “Varicose Vein Treatment Market Share, Size, Trends, Industry Analysis Report, By Treatment Mode (Endovenous Ablation, Injection Sclerotherapy, Surgical Ligation/Stripping); By Products; By End User; By Region; Segment Forecast, 2023 - 2032” gives a detailed insight into current market dynamics and provides analysis on future market growth.

Varicose veins are veins that are unusually enlarged and may protrude close to the skin's surface. Legs are most prone to developing these blue, red, or purple veins, which can occasionally resemble squiggly or rope-like lines. Over 30% of people in Western countries suffer from varicose veins, a prevalent symptom of chronic venous illness. Between the ages of 40 and 80, more than 11 million men and 22 million women in America suffer from chronic venous illness. If neglected, it can lead to several health issues, including leg ulcers and eventually amputations.

The first-ever genetic risk score for predicting the likelihood that patients with varicose veins will need surgery is established in a new international study by Oxford researchers and published on June 2, 2022, in Nature Communications. The study also points the way towards potential new treatments. This represents a rise in research and development activities for treating varicose veins. This can help people with varicose vein problems cure their problems effectively with rising varicose vein treatments in the future.

Growing clinics investing in varicose vein treatment are driving the expansion of varicose vein treatment on a global level. Veincentre Clinic was established in Woking, aiming to provide patients with safe, efficient, and less invasive laser therapy to get rid of varicose veins and thread veins. Endovenous laser ablation (Evla) and foam sclerotherapy are two treatments offered in this clinic, where these procedures are regarded as effective varicose vein treatments by the National Institute of Health and Care Excellence. As consumers face rising varicose vein issues due to immobility in the workplace, there is more likely to be a growing demand for varicose vein treatments in the coming years.

Varicose Vein Treatment Market Report Highlights

Endovenous Ablation will grow at rapid pace, due to its convenience and low hospitalization.

Radiofrequency Ablation Devices held the largest share owing to its effectiveness in treatment.

Specialized Clinics segment garnered the largest share due to personalized treatment and expertise in treating varicose vein issues.

APAC will grow at steady pace owing to growing awareness programs on health issues.

The global players include AngioDynamics, Medtronic, Syneron Medical, Alma Lasers, Alna-Medical System, LSO Medical, WON TECH, Intros Medical Laser, Energist, Dornier Medtech, Theraclion & I-VASC.

Polaris Market Research has segmented the varicose vein treatment market report based on treatment mode, products, end user and region:

Varicose Vein Treatment, Treatment Mode Outlook (Revenue - USD Million, 2019 - 2032)

Endovenous Ablation

Injection Sclerotherapy

Surgical Ligation/Stripping

Varicose Vein Treatment, Products Outlook (Revenue - USD Million, 2019 - 2032)

Ablation Devices

Radiofrequency Ablation Devices

Laser Ablation Devices

Venous Closure Products

Varicose Vein Treatment, End User Outlook (Revenue - USD Million, 2019 - 2032)

Hospitals

Ambulatory Surgical Centres

Specialized Clinics

Varicose Vein Treatment, Regional Outlook (Revenue - USD Million, 2019 - 2032)

North America

U.S.

Canada

Europe

Germany

UK

France

Italy

Spain

Russia

Netherlands

Asia Pacific

China

India

Japan

South Korea

Indonesia

Malaysia

Latin America

Argentina

Brazil

Mexico

Middle East & Africa

UAE

Saudi Arabia

Israel

South Africa